Lienhardt & Partner Core Strategy Fund (CSF) I-CHF

Reference Data

ISIN CH0235616270
Valor Number 23561627
Bloomberg Global ID
Fund Name Lienhardt & Partner Core Strategy Fund (CSF) I-CHF
Fund Provider Lienhardt & Partner Privatbank Zürich AG Phone: +41 31 399 31 11
E-Mail: info@lienhardt.ch
Web: https://www.lienhardt-bern.ch
Fund Provider Lienhardt & Partner Privatbank Zürich AG
Representative in Switzerland
Distributor(s) Lienhardt & Partner Privatbank Zürich AG
Phone: 41 31 399 31 11
Asset Class Asset Allocation
EFC Category
Distribution Policy Accumulation
Home Country Switzerland
Issuing Condition The fund management company and/or distributor charges an issuing commission (different commissions can be charged for the same fund depending on the sales channel)
Redemption Condition The fund does not charge any redemption commission and/or fees (units are redeemed at the NAV)
Investment Strategy *** The fund invests in shares and first-class bonds.
Peculiarities

Fund Prices

Current Price * 126.08 CHF 12.05.2025
Previous Price * 124.72 CHF 09.05.2025
52 Week High * 130.46 CHF 13.02.2025
52 Week Low * 117.18 CHF 09.04.2025
NAV * 126.08 CHF 12.05.2025
Issue Price *
Redemption Price *
Closing Price *
Indicative Minimum Price
Fund Assets *** 103,818,654
Unit/Share Assets *** 15,289,063
Trading Information SIX

Performance

YTD Performance +0.77% 31.12.2024
12.05.2025
1 month +5.77% 14.04.2025
12.05.2025
3 months -3.02% 12.02.2025
12.05.2025
6 months +0.50% 12.11.2024
12.05.2025
1 year +1.90% 13.05.2024
12.05.2025
2 years +9.38% 12.05.2023
12.05.2025
3 years +4.20% 12.05.2022
12.05.2025
5 years +18.42% 12.05.2020
12.05.2025

Tax Data

Equity Participation Rate in %
Share of Total Fund Assets in %
Real Estate Rate in %
ADDI
ADDI Date

Top 10 Holdings ***

StructGSQrtxMdfdStgyBlmbrgCmdIdxTRCCHFH 6.16%
Synchrony Swiss Government Bonds 5.25%
Roche Holding AG 4.37%
Amundi BlmbrgEqualweightCmdexAgrETFAcc 3.89%
Nestle SA 3.36%
iShares MSCI Emerging Markets ETF 2.91%
DH Switzerland Finance SA 1.13% 2.86%
Pfandbriefbank schweizerischer Hypothekarinstitute AG 0.63% 2.81%
UBS (CH) PF Swiss Residential Ord 2.77%
Novartis AG Registered Shares 2.76%
Last data update 31.03.2025

Cost / Risk

TER 0.89%
TER date 31.12.2024
Performance Fee ***
PTR 85.00%
Max. Management Fee *** 0.70%
Ongoing Charges *** 0.88%
SRRI ***
SRRI date *** 30.04.2025

Breakdowns

Countries ***

Stock Sectors ***

Bond Sectors ***


* NAV / Issue Price exclusive commissions, for listed funds NAV or closing price
** Calculation of interim profit followed § 9 Satz 2 InvStG
*** Data source: Morningstar (Data is based on the rescaled long position of the holdings)